Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bristow

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Cancer Research|March 9, 2005
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutationsGudrun Pohl, Chung-Liang Ho, Robert J Kurman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Patient-specific PTV margins in radiotherapy for bladder cancer - a feasibility study using cone beam CTShaun Tolan, Vickie Kong, Tara Rosewall, et al.
Practical Radiation Oncology|September 7, 2014
Deriving patient-specific planning target volume for partial bladder image guided radiation therapyVickie Kong, Tara Rosewall, Susan Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2008
A randomized comparison of interfraction and intrafraction prostate motion with and without abdominal compressionTara Rosewall, Peter Chung, Andrew Bayley, et al.
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Radiation Oncology (London, England)|March 11, 2017
The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancerAli Hosni, Tara Rosewall, Timothy Craig, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancerMichael Sia, George Rodrigues, Cynthia Menard, et al.
BMJ Oncology|March 6, 2025
UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first resultsD Gareth Evans, George Burghel, Helene Schlecht, et al.
The Journal of General and Applied Microbiology|November 13, 2018
Host selectively contributes to shaping intestinal microbiota of carnivorous and omnivorous fishKristian Daly, Jennifer Kelly, Andrew W Moran, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancerHester Lieng, Melania Pintilie, Andrew Bayley, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Cancer Research|March 9, 2005
Inactivation of the mitogen-activated protein kinase pathway as a potential target-based therapy in ovarian serous tumors with KRAS or BRAF mutationsGudrun Pohl, Chung-Liang Ho, Robert J Kurman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 31, 2011
Patient-specific PTV margins in radiotherapy for bladder cancer - a feasibility study using cone beam CTShaun Tolan, Vickie Kong, Tara Rosewall, et al.
Practical Radiation Oncology|September 7, 2014
Deriving patient-specific planning target volume for partial bladder image guided radiation therapyVickie Kong, Tara Rosewall, Susan Chen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 19, 2008
A randomized comparison of interfraction and intrafraction prostate motion with and without abdominal compressionTara Rosewall, Peter Chung, Andrew Bayley, et al.
Journal of the National Cancer Institute|July 12, 2012
Association between germline HOXB13 G84E mutation and risk of prostate cancerMohammad R Akbari, John Trachtenberg, Justin Lee, et al.
Radiation Oncology (London, England)|March 11, 2017
The effect of bowel preparation regime on interfraction rectal filling variation during image guided radiotherapy for prostate cancerAli Hosni, Tara Rosewall, Timothy Craig, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|April 7, 2010
Treatment-related toxicity and symptom-related bother following postoperative radiotherapy for prostate cancerMichael Sia, George Rodrigues, Cynthia Menard, et al.
BMJ Oncology|March 6, 2025
UK-based clinical testing programme for somatic and germline BRCA1/2, ATM and CDK12 mutations in prostate cancer: first resultsD Gareth Evans, George Burghel, Helene Schlecht, et al.
The Journal of General and Applied Microbiology|November 13, 2018
Host selectively contributes to shaping intestinal microbiota of carnivorous and omnivorous fishKristian Daly, Jennifer Kelly, Andrew W Moran, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 14, 2016
Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancerHester Lieng, Melania Pintilie, Andrew Bayley, et al.
Pageof 6